| [1] |
White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol,2012,10:1342-1359.
|
| [2] |
Dyson JK, McPherson S, Anstee QM. Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. Postgrad Med J,2014,90:254-266.
|
| [3] |
Lemoine M, Serfaty L.Nonalcoholic fatty liver disease. Presse Med, 2012, 41:169-189.
|
| [4] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).胃肠病学和肝病学杂志,2010,19:483-487.
|
| [5] |
Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol,2012,10:837-858.
|
| [6] |
Marra F, Bertolani C. Adipokines in liver diseases. Hepatology, 2009,50: 957-969.
|
| [7] |
谢伶俐,周力,李丽滨,等.TNF-α和IL-6在非酒精性脂肪性肝病患者血清中的水平及意义.世界华人消化杂志,2010,18:1492-1496.
|
| [8] |
Chueh WH, Lin JY. Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. J Agric Food Chem,2011,59:8021-8027.
|
| [9] |
Chueh WH, Lin JY. Protective effect of berberine on serum glucose levels in non-obese diabetic mice. Int Immunopharmacol,2012,12:534-538.
|
| [10] |
Yang QH, Hu SP, Zhang YP, et al. Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c-Jun N-terminal kinase in upffer cells of rats with fatty liver disease. Chin J Integr Med, 2012,18:769-774.
|
| [11] |
Li J, Pan Y, Kan M,et al. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase. Life Sci,2014,98:24-30.
|
| [12] |
Dong H, Lu FE, Zhao L. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Chin J Integr Med,2012,18:152-160.
|
| [13] |
Teodoro JS, Duarte FV, Gomes AP,et al. Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation. Mitochondrion, 2013,13:637-646.
|
| [14] |
Liu Y, Zhang L, Song H, et al. Update on berberine in nonalcoholic Fatty liver disease. Evid Based Complement Alternat Med,2013,2013:308134.
|
| [15] |
Han L, Yang QH, Zhang YP,et al. Intervention of berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2015,35:314-319.
|
| [16] |
Guo T, Woo SL, Guo X,et al. Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity. Sci Rep, 2016,6:22612.
|
| [17] |
Cao Y, Pan Q, Cai W,et al. Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. Arch Iran Med,2016,19:197-203.
|
| [18] |
Yan HM, Xia MF, Wang Y,et al. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One, 2015,10:e0134172.
|
